Previous Article | Next Article 
Journal of Clinical Microbiology, October 2007, p. 3352-3359, Vol. 45, No. 10
0095-1137/07/$08.00+0 doi:10.1128/JCM.01284-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004
Shawn R. Lockhart,1*
Murray A. Abramson,2
Susan E. Beekmann,1
Gale Gallagher,2
Stefan Riedel,1
Daniel J. Diekema,1
John P. Quinn,3 and
Gary V. Doern1
University of Iowa Hospital and Clinics, Division of Clinical Microbiology, Iowa City, Iowa,1
Merck and Co., Inc., Merck Research Laboratories, Upper Gwynedd, Pennsylvania,2
Cook County Hospital, Division of Infectious Diseases, Chicago, Illinois3
Received 26 June 2007/
Returned for modification 6 August 2007/
Accepted 10 August 2007
During the 12-year period from 1993 to 2004, antimicrobial susceptibility profiles of 74,394 gram-negative bacillus isolates recovered from intensive care unit (ICU) patients in United States hospitals were determined by participating hospitals and collected in a central location. MICs for 12 different agents were determined using a standardized broth microdilution method. The 11 organisms most frequently isolated were Pseudomonas aeruginosa (22.2%), Escherichia coli (18.8%), Klebsiella pneumoniae (14.2%), Enterobacter cloacae (9.1%), Acinetobacter spp. (6.2%), Serratia marcescens (5.5%), Enterobacter aerogenes (4.4%), Stenotrophomonas maltophilia (4.3%), Proteus mirabilis (4.0%), Klebsiella oxytoca (2.7%), and Citrobacter freundii (2.0%). Specimen sources included the lower respiratory tract (52.1%), urine (17.3%), and blood (14.2%). Rates of resistance to many of the antibiotics tested remained stable during the 12-year study period. Carbapenems were the most active drugs tested against most of the bacterial species. E. coli and P. mirabilis remained susceptible to most of the drugs tested. Mean rates of resistance to 9 of the 12 drugs tested increased with Acinetobacter spp. Rates of resistance to ciprofloxacin increased over the study period for most species. Ceftazidime was the only agent to which a number of species (Acinetobacter spp., C. freundii, E. aerogenes, K. pneumoniae, P. aeruginosa, and S. marcescens) became more susceptible. The prevalence of multidrug resistance, defined as resistance to at least one extended-spectrum cephalosporin, one aminoglycoside, and ciprofloxacin, increased substantially among ICU isolates of Acinetobacter spp., P. aeruginosa, K. pneumoniae, and E. cloacae.
* Corresponding author. Mailing address: University of Iowa Hospitals and Clinics, Department of Pathology-6008 BT GH, 200 Hawkins Drive, Iowa City, IA 52242-1009. Phone: (319) 356-2104. Fax: (319) 356-4916. E-mail:
shawn-lockhart{at}uiowa.edu
Published ahead of print on 22 August 2007.
Journal of Clinical Microbiology, October 2007, p. 3352-3359, Vol. 45, No. 10
0095-1137/07/$08.00+0 doi:10.1128/JCM.01284-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Al-Hasan, M. N., Lahr, B. D., Eckel-Passow, J. E., Baddour, L. M.
(2009). Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother
64: 169-174
[Abstract]
[Full Text]
-
Nam, H. M., Lim, S. K., Kang, H. M., Kim, J. M., Moon, J. S., Jang, K. C., Kim, J. M., Joo, Y. S., Jung, S. C.
(2009). Prevalence and antimicrobial susceptibility of gram-negative bacteria isolated from bovine mastitis between 2003 and 2008 in Korea. J DAIRY SCI
92: 2020-2026
[Abstract]
[Full Text]
-
Adams, M. D., Goglin, K., Molyneaux, N., Hujer, K. M., Lavender, H., Jamison, J. J., MacDonald, I. J., Martin, K. M., Russo, T., Campagnari, A. A., Hujer, A. M., Bonomo, R. A., Gill, S. R.
(2008). Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii. J. Bacteriol.
190: 8053-8064
[Abstract]
[Full Text]
-
Ge, Y., Biek, D., Talbot, G. H., Sahm, D. F.
(2008). In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States. Antimicrob. Agents Chemother.
52: 3398-3407
[Abstract]
[Full Text]
-
Marschall, J., Agniel, D., Fraser, V. J., Doherty, J., Warren, D. K.
(2008). Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes. J Antimicrob Chemother
61: 1376-1383
[Abstract]
[Full Text]
-
Burgess, D. S., Rapp, R. P.
(2008). Bugs versus drugs: Addressing the pharmacist's challenge. Am J Health Syst Pharm
65: S4-S15
[Abstract]
[Full Text]
-
Zhanel, G. G., DeCorby, M., Laing, N., Weshnoweski, B., Vashisht, R., Tailor, F., Nichol, K. A., Wierzbowski, A., Baudry, P. J., Karlowsky, J. A., Lagace-Wiens, P., Walkty, A., McCracken, M., Mulvey, M. R., Johnson, J., The Canadian Antimicrobial Resistance Alliance (CA, , Hoban, D. J.
(2008). Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006. Antimicrob. Agents Chemother.
52: 1430-1437
[Abstract]
[Full Text]